Perioperative management of long-acting glucagon-like peptide-1 (GLP-1) receptor agonists. Comment on Br J Anaesth 2024; 132: 644-8.
作者信息
Potnuru Paul P, Hernandez Nadia, Nwokolo Omonele O, Sen Sudipta
机构信息
Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, University of Texas Health Science Center at Houston (UTHealth Houston), Houston, TX, USA.
Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, University of Texas Health Science Center at Houston (UTHealth Houston), Houston, TX, USA.
出版信息
Br J Anaesth. 2024 Oct;133(4):884-886. doi: 10.1016/j.bja.2024.05.043. Epub 2024 Jul 25.
PMID:39060159
Abstract
摘要
相似文献
1
Perioperative management of long-acting glucagon-like peptide-1 (GLP-1) receptor agonists. Comment on Br J Anaesth 2024; 132: 644-8.长效胰高血糖素样肽-1（GLP-1）受体激动剂的围手术期管理。对《英国麻醉学杂志》2024年；132: 644 - 8的评论
Br J Anaesth. 2024 Oct;133(4):884-886. doi: 10.1016/j.bja.2024.05.043. Epub 2024 Jul 25.
2
Preoperative continuation of GLP-1 receptor agonists. Response to Br J Anaesth 2024; 133: 437-8.胰高血糖素样肽-1受体激动剂的术前持续使用。对《英国麻醉学杂志》2024年；133: 437 - 8的回应。
Br J Anaesth. 2024 Oct;133(4):882-883. doi: 10.1016/j.bja.2024.06.026. Epub 2024 Jul 19.
3
Perioperative management of long-acting glucagon-like peptide-1 (GLP-1) receptor agonists: concerns for delayed gastric emptying and pulmonary aspiration.长效胰高血糖素样肽-1（GLP-1）受体激动剂的围手术期管理：关注胃排空延迟和肺吸入的问题。
Br J Anaesth. 2024 Apr;132(4):644-648. doi: 10.1016/j.bja.2024.01.001. Epub 2024 Jan 29.
4
Comparison of societal guidance on perioperative management of glucagon-like peptide-1 receptor agonists: implications for clinical practice and future investigations.比较胰高血糖素样肽-1 受体激动剂围手术期管理的社会指导：对临床实践和未来研究的影响。
Can J Anaesth. 2024 Sep;71(9):1302-1315. doi: 10.1007/s12630-024-02810-5. Epub 2024 Aug 26.
5
Quantified Metrics of Gastric Emptying Delay by Glucagon-Like Peptide-1 Agonists: A Systematic Review and Meta-Analysis With Insights for Periprocedural Management.胰高血糖素样肽-1 激动剂胃排空延迟的定量指标：系统评价和荟萃分析及其对围手术期管理的启示。
Am J Gastroenterol. 2024 Jun 1;119(6):1126-1140. doi: 10.14309/ajg.0000000000002820. Epub 2024 Apr 18.
6
Glucagon like peptide-1 and its receptor agonists: Their roles in management of Type 2 diabetes mellitus.胰高血糖素样肽-1及其受体激动剂：它们在2型糖尿病管理中的作用。
Diabetes Metab Syndr. 2017 Jul-Sep;11(3):225-230. doi: 10.1016/j.dsx.2016.09.003. Epub 2016 Sep 15.
7
[A new era for incretins : from GLP-1 receptor agonists to co-agonists and poly-agonists].肠促胰岛素的新时代：从胰高糖素样肽-1受体激动剂到协同激动剂和多靶点激动剂
Rev Med Liege. 2024 Sep;79(9):605-612.
8
Xenopus-derived glucagon-like peptide-1 and polyethylene-glycosylated glucagon-like peptide-1 receptor agonists: long-acting hypoglycaemic and insulinotropic activities with potential therapeutic utilities.来源于非洲爪蟾的胰高血糖素样肽-1 及聚乙二醇化胰高血糖素样肽-1 受体激动剂：具有潜在治疗用途的长效降血糖和胰岛素促分泌作用。
Br J Pharmacol. 2018 Feb;175(3):544-557. doi: 10.1111/bph.14107. Epub 2018 Jan 8.
9
Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same?胰高血糖素样肽-1 受体激动剂在 2 型糖尿病治疗中的应用：它们都一样吗？
Diabetes Metab Res Rev. 2019 Jan;35(1):e3070. doi: 10.1002/dmrr.3070. Epub 2018 Oct 4.
10
Glucagon-like peptide-1 receptor agonists: a narrative review of clinical pharmacology and implications for peri-operative practice.胰高血糖素样肽-1 受体激动剂：临床药理学的叙述性综述及其对围手术期实践的影响。
Anaesthesia. 2024 Jul;79(7):735-747. doi: 10.1111/anae.16306. Epub 2024 May 13.
Zotero 插件